Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reflections on treatment of COVID-19 with traditional Chinese medicine
Hua Luo, Yan Gao, Jian Zou, et al.
Chinese Medicine (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Traditional Chinese Medicine (TCM) in the treatment of COVID-19 and other viral infections: Efficacies and mechanisms
Kai Huang, Pan Zhang, H. H. Zhang, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107843-107843
Open Access | Times Cited: 390
Traditional Chinese medicine in COVID-19
Ming Lyu, Guanwei Fan, Guangxu Xiao, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 11, Iss. 11, pp. 3337-3363
Open Access | Times Cited: 178
Advances in the development of therapeutic strategies against COVID-19 and perspectives in the drug design for emerging SARS-CoV-2 variants
Jialing Yin, Chengcheng Li, Chunhong Ye, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 824-837
Open Access | Times Cited: 65
Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review
Yan Huang, Qiong Ling, Anne Manyande, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 39
CPMI-ChatGLM: parameter-efficient fine-tuning ChatGLM with Chinese patent medicine instructions
Can Liu, Kaijie Sun, Qingqing Zhou, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
Md. Mominur Rahman, Md. Rezaul Islam, Shopnil Akash, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 30
Kaempferol has potential anti‐coronavirus disease 2019 (COVID‐19) targets based on bioinformatics analyses and pharmacological effects on endotoxin‐induced cytokine storm
Yaoxiang Sun, Qing Tao, Yang Cao, et al.
Phytotherapy Research (2023) Vol. 37, Iss. 6, pp. 2290-2304
Closed Access | Times Cited: 18
New insights for infection mechanism and potential targets of COVID-19: Three Chinese patent medicines and three Chinese medicine formulas as promising therapeutic approaches
Kexin Jia, Yijie Li, Tiegang Liu, et al.
Chinese Herbal Medicines (2023) Vol. 15, Iss. 2, pp. 157-168
Open Access | Times Cited: 14
Integrating Chinese and western medicine for COVID‐19: A living evidence‐based guideline (version 1)
Long Ge, Hongfei Zhu, Qi Wang, et al.
Journal of Evidence-Based Medicine (2021) Vol. 14, Iss. 4, pp. 313-332
Open Access | Times Cited: 27
Quantitative evaluation of traditional Chinese medicine development policy: A PMC index model approach
Ciran Yang, Shicheng Yin, Dan Cui, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 20
Do Diet and Dietary Supplements Mitigate Clinical Outcomes in COVID-19?
Bhavdeep Singh, Eli Eshaghian, Judith Chuang, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1909-1909
Open Access | Times Cited: 19
Exploring the pharmacological mechanisms of star anise against COVID‐19 using network pharmacology and molecular docking
Ning Li, Ya Gao, Lingfei Liu, et al.
Food Safety and Health (2024)
Open Access | Times Cited: 4
Virtual Screening and Molecular Simulation Uncover Potent Traditional Chinese Medicine Small Molecules Against SARS‐CoV‐2 Mpro
Di Han, H. J. Yang, Yunlong Gao, et al.
ChemistrySelect (2025) Vol. 10, Iss. 12
Closed Access
The Extracts of Polygonum cuspidatum Root and Rhizome Block the Entry of SARS-CoV-2 Wild-Type and Omicron Pseudotyped Viruses via Inhibition of the S-Protein and 3CL Protease
Shengying Lin, Xiaoyang Wang, Roy Wai-Lun Tang, et al.
Molecules (2022) Vol. 27, Iss. 12, pp. 3806-3806
Open Access | Times Cited: 17
Chinese herbal prescriptions for COVID-19 management: Special reference to Taiwan Chingguan Yihau (NRICM101)
Yi‐Chang Su, Guan‐Jhong Huang, Jaung‐Geng Lin
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 17
Efficacy analysis and research progress of complementary and alternative medicines in the adjuvant treatment of COVID-19
Jaung‐Geng Lin, Guan‐Jhong Huang, Yi‐Chang Su
Journal of Biomedical Science (2023) Vol. 30, Iss. 1
Open Access | Times Cited: 10
Methyl rosmarinate is an allosteric inhibitor of SARS-cov-2 3 C L protease as a potential candidate against SARS-cov-2 infection
Hongtao Li, Meng Sun, Fuzhi Lei, et al.
Antiviral Research (2024) Vol. 224, pp. 105841-105841
Closed Access | Times Cited: 3
Wen-Yi and Chinese medicine: Why we need to pay attention?
Yibai Xiong, Linlin Bao, Yan Ma, et al.
Science Bulletin (2024) Vol. 69, Iss. 11, pp. 1617-1622
Open Access | Times Cited: 3
Traditional Chinese medicine as a protective strategy against chemotherapy-induced cardiotoxicity: An overview of the literature
Junwei Wang, Hong Shao, You-Ni Zhang, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 15, Iss. 2, pp. 107-118
Open Access | Times Cited: 3
Panax notoginseng Saponins Modulate the Inflammatory Response and Improve IBD-Like Symptoms via TLR/NF-κB and MAPK Signaling Pathways
Hua Luo, Chi Teng Vong, Dechao Tan, et al.
The American Journal of Chinese Medicine (2021) Vol. 49, Iss. 04, pp. 925-939
Closed Access | Times Cited: 21
Systematic characterization of chemical constituents in Mahuang decoction by UHPLC tandem linear ion trap‐Orbitrap mass spectrometry coupled with feature‐based molecular networking
Ling Chen, Changliang Yao, Jiayuan Li, et al.
Journal of Separation Science (2021) Vol. 44, Iss. 14, pp. 2717-2727
Closed Access | Times Cited: 18
Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration
Shanshan Li, Tianyue Feng, Yingwen Zhang, et al.
Journal of Ethnopharmacology (2023) Vol. 320, pp. 117467-117467
Closed Access | Times Cited: 7
Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies
Mu-Feng Xiang, Chengtao Jin, Lihua Sun, et al.
Chinese Medicine (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Chinese Medicine in Fighting against Covid-19: Role and Inspiration
Jingen Li, Hao Xu
Chinese Journal of Integrative Medicine (2021) Vol. 27, Iss. 1, pp. 3-6
Open Access | Times Cited: 16
Therapeutic mechanisms and impact of traditional Chinese medicine on COVID-19 and other influenza diseases
Taif Shah, Ke-Yao Xia, Zahir Shah, et al.
Pharmacological Research - Modern Chinese Medicine (2021) Vol. 2, pp. 100029-100029
Open Access | Times Cited: 15
Page 1 - Next Page

Scroll to top